|
Post by factspls88 on Apr 3, 2017 13:03:25 GMT -5
Just when you thought it couldn't get too much worse.
|
|
|
Post by babaoriley on Apr 3, 2017 13:12:04 GMT -5
I guess it's never safe to think that with biotech stocks, factspls88.
|
|
|
Post by ilovekauai on Apr 3, 2017 13:17:09 GMT -5
Well, that wasn't fun to witness. Stock has been heading south for past 2 weeks now. I wonder what caused today's sudden drop. And now it seems to be rebounding. Crazy day here.
|
|
|
Post by slugworth008 on Apr 3, 2017 14:42:57 GMT -5
Just when you thought it couldn't get too much worse. Absolutely pathetic
|
|
|
Post by cretin11 on Apr 3, 2017 17:05:45 GMT -5
Eleven consecutive down days, that's gotta be a record.
|
|
|
Post by anderson on Apr 3, 2017 17:11:20 GMT -5
|
|
|
Post by lakers on Apr 3, 2017 17:30:42 GMT -5
Eleven consecutive down days, that's gotta be a record. They use flash crash again to take out weak hands. It looks like shorts are determined to push pps below $1 again (20 cents pre-split). Only some good news ... Will stop the bleeding.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 3, 2017 18:51:49 GMT -5
You've gotten plenty of good news in the past 6 months. Nothing is getting it done until they add 1000's of scripts. Why would anyone cover? Longs know better then anyone how good of a short this is.
|
|
|
Post by sayhey24 on Apr 3, 2017 19:45:05 GMT -5
You've gotten plenty of good news in the past 6 months. Nothing is getting it done until they add 1000's of scripts. Why would anyone cover? Longs know better then anyone how good of a short this is. I suspect it will take awhile until they are adding 1000's of scripts. I was surprised about the Medscape presentation and their poll. It actually seems some doctors are now seeing that afrezza may be an option. twitter.com/MedscapeCME?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5EauthorI thought that was some good news if its true. I also thought the news about metformin PWDs having twice the dementia rate as one more reason to move them to insulin as good news for afrezza but not good for the current metformin users. I doubt any of this will turn the pps. It would be nice if they could get one deal done on something to turn the pps until there are 1000's of scripts.
|
|
|
Post by dreamboatcruise on Apr 4, 2017 16:35:07 GMT -5
You've gotten plenty of good news in the past 6 months. Nothing is getting it done until they add 1000's of scripts. Why would anyone cover? Longs know better then anyone how good of a short this is. I suspect it will take awhile until they are adding 1000's of scripts. I was surprised about the Medscape presentation and their poll. It actually seems some doctors are now seeing that afrezza may be an option. twitter.com/MedscapeCME?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5EauthorI thought that was some good news if its true. I also thought the news about metformin PWDs having twice the dementia rate as one more reason to move them to insulin as good news for afrezza but not good for the current metformin users. I doubt any of this will turn the pps. It would be nice if they could get one deal done on something to turn the pps until there are 1000's of scripts. I doubt doctors would base prescribing decisions on a single retrospective data study (sorting through old data) on Metformin that directly contradicts other trials. Even the author of that presentation has stressed a need for actual "prospective" studies given that their results conflict with earlier data.
|
|
|
Post by agedhippie on Apr 4, 2017 16:51:05 GMT -5
I suspect it will take awhile until they are adding 1000's of scripts. I was surprised about the Medscape presentation and their poll. It actually seems some doctors are now seeing that afrezza may be an option. twitter.com/MedscapeCME?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5EauthorI thought that was some good news if its true. I also thought the news about metformin PWDs having twice the dementia rate as one more reason to move them to insulin as good news for afrezza but not good for the current metformin users. I doubt any of this will turn the pps. It would be nice if they could get one deal done on something to turn the pps until there are 1000's of scripts. I doubt doctors would base prescribing decisions on a single retrospective data study (sorting through old data) on Metformin that directly contradicts other trials. Even the author of that presentation has stressed a need for actual "prospective" studies given that their results conflict with earlier data. Not to mention that if they did move them off metformin it would be to other non-insulin drugs, then to basal insulin, and then just maybe Afrezza one day.
|
|
|
Post by buyitonsale on Apr 4, 2017 18:39:22 GMT -5
There has to be a market cap valuation that could not be resisted by somebody that understands IP. I keep thinking that we have gone down beyond it but apparently not. Is Mann group waiting for 30M to buy up all shares? Matt keeps mentioning that 30M loan over and over...
Well, we will find out eventually what that magic number is but I hope that Mann group is protecting the majority stake in the company. I never understood why they would not own at least 50%. We are now talking about $70M for someone to possibly take control of an FDA approved drug with worldwide distribution potential and other TS applications. And what if that someone has bad intentions...
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 4, 2017 19:03:55 GMT -5
Its not 70 million. Its 70 million plus the debt and the cost to run the safety trials.
|
|
|
Post by peppy on Apr 4, 2017 19:22:42 GMT -5
the debt can be written off over 10 years?
|
|
|
Post by bioexec25 on Apr 4, 2017 19:25:43 GMT -5
Its not 70 million. Its 70 million plus the debt and the cost to run the safety trials. And a 20 year old technology with practically the whole of the BP establishment against. Patent cliff not all that far out and superior disruptive therapies coming sooner than we think. Other than that surprised someone hasn't snatched it up.
|
|